Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Cotter S"" wg kryterium: Autor


Tytuł :
Mushroom-derived maitake PETfraction as single agent for the treatment of lymphoma in dogs.
Autorzy :
Griessmayr PC; Harrington Oncology Program, Cummings School of Veterinary Medicine at Tufts University, North Grafton, MA 01536, USA.
Gauthier M
Barber LG
Cotter SM
Pokaż więcej
Źródło :
Journal of veterinary internal medicine [J Vet Intern Med] 2007 Nov-Dec; Vol. 21 (6), pp. 1409-12.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents, Phytogenic/*therapeutic use
Dog Diseases/*drug therapy
Grifola/*chemistry
Lymphoma/*veterinary
Phytotherapy/*veterinary
Plant Extracts/*therapeutic use
Animals ; Antineoplastic Agents, Phytogenic/adverse effects ; Antineoplastic Agents, Phytogenic/chemistry ; Dogs ; Female ; Lymphoma/drug therapy ; Male ; Plant Extracts/adverse effects ; Plant Extracts/chemistry
Czasopismo naukowe
Tytuł :
Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma.
Autorzy :
Moore AS; Harrington Oncology Program, Tufts University School of Veterinary Medicine, North Grafton, MA 01536, USA. />Cotter SM
Rand WM
Wood CA
Williams LE
London CA
Frimberger AE
L'Heureux DA
Pokaż więcej
Źródło :
Journal of veterinary internal medicine [J Vet Intern Med] 2001 Jul-Aug; Vol. 15 (4), pp. 348-54.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Dog Diseases/*drug therapy
Lymphoma/*veterinary
Animals ; Asparaginase/administration & dosage ; Breeding ; Cyclophosphamide/administration & dosage ; Disease-Free Survival ; Dogs ; Doxorubicin/administration & dosage ; Drug Administration Schedule ; Female ; Lymphoma/drug therapy ; Male ; Prednisone/administration & dosage ; Records/veterinary ; Retrospective Studies ; Treatment Outcome ; Vincristine/administration & dosage
Czasopismo naukowe
Tytuł :
Single agent chemotherapy with doxorubicin for feline lymphoma: a retrospective study of 19 cases (1994-1997).
Autorzy :
Kristal O; Tufts University, School of Veterinary Medicine, North Grafton, MA 01536, USA.
Lana SE
Ogilvie GK
Rand WM
Cotter SM
Moore AS
Pokaż więcej
Źródło :
Journal of veterinary internal medicine [J Vet Intern Med] 2001 Mar-Apr; Vol. 15 (2), pp. 125-30.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Cat Diseases/*drug therapy
Cat Diseases/*mortality
Doxorubicin/*therapeutic use
Lymphoma/*veterinary
Animals ; Antineoplastic Agents/administration & dosage ; Cats ; Doxorubicin/administration & dosage ; Drug Administration Schedule ; Female ; Infusions, Intravenous/veterinary ; Lymphoma/drug therapy ; Lymphoma/mortality ; Male ; Records/veterinary ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
The histologic classification of 602 cases of feline lymphoproliferative disease using the National Cancer Institute working formulation.
Autorzy :
Valli VE; College of Veterinary Medicine, University of Illinois, Urbana 61802, USA.
Jacobs RM
Norris A
Couto CG
Morrison WB
McCaw D
Cotter S
Ogilvie G
Moore A
Pokaż więcej
Źródło :
Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc [J Vet Diagn Invest] 2000 Jul; Vol. 12 (4), pp. 295-306.
Typ publikacji :
Journal Article
MeSH Terms :
Cat Diseases/*pathology
Lymphoma/*veterinary
Animals ; Biopsy ; Cat Diseases/classification ; Cats ; Female ; Leukemia Virus, Feline/genetics ; Lymphoma/classification ; Lymphoma/pathology ; Male ; Miosis ; Mitosis ; Necrosis ; Sclerosis
Czasopismo naukowe
Tytuł :
Evaluation of ifosfamide for treatment of various canine neoplasms.
Autorzy :
Rassnick KM; Harrington Oncology Program, School of Veterinary Medicine, Tufts University, North Grafton, MA 01536, USA. />Frimberger AE
Wood CA
Williams LE
Cotter SM
Moore AS
Pokaż więcej
Źródło :
Journal of veterinary internal medicine [J Vet Intern Med] 2000 May-Jun; Vol. 14 (3), pp. 271-6.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents, Alkylating/*therapeutic use
Dog Diseases/*drug therapy
Ifosfamide/*therapeutic use
Lymphoma/*veterinary
Sarcoma/*veterinary
Animals ; Dog Diseases/mortality ; Dogs ; Female ; Lymphoma/drug therapy ; Lymphoma/mortality ; Male ; Massachusetts/epidemiology ; Records/veterinary ; Retrospective Studies ; Sarcoma/drug therapy ; Sarcoma/mortality ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Lomustine (CCNU) for the treatment of resistant lymphoma in dogs.
Autorzy :
Moore AS; Harrington Oncology Program, Tufts University School of Veterinary Medicine, North Grafton, MA 01536, USA.
London CA
Wood CA
Williams LE
Cotter SM
L'Heureux DA
Frimberger AE
Pokaż więcej
Źródło :
Journal of veterinary internal medicine [J Vet Intern Med] 1999 Sep-Oct; Vol. 13 (5), pp. 395-8.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents, Alkylating/*therapeutic use
Dog Diseases/*drug therapy
Lomustine/*therapeutic use
Lymphoma/*veterinary
Animals ; Antineoplastic Agents, Alkylating/adverse effects ; Dogs ; Drug Resistance, Neoplasm ; Female ; Lomustine/adverse effects ; Lymphoma/drug therapy ; Male ; Neutropenia/chemically induced ; Recurrence ; Thrombocytopenia/chemically induced ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Evaluation of a multidrug chemotherapy protocol (ACOPA II) in dogs with lymphoma.
Autorzy :
Myers NC 3rd; Department of Medicine, Foster Hospital for Small Animals, Tufts University, School of Veterinary Medicine, North Grafton, USA.
Moore AS
Rand WM
Gliatto J
Cotter SM
Pokaż więcej
Źródło :
Journal of veterinary internal medicine [J Vet Intern Med] 1997 Nov-Dec; Vol. 11 (6), pp. 333-9.
Typ publikacji :
Clinical Trial; Controlled Clinical Trial; Journal Article
MeSH Terms :
Dog Diseases*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Lymphoma/*veterinary
Animals ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Asparaginase/administration & dosage ; Asparaginase/therapeutic use ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/therapeutic use ; Dogs ; Doxorubicin/administration & dosage ; Doxorubicin/therapeutic use ; Lymphoma/drug therapy ; Lymphoma/mortality ; Lymphoma/pathology ; Neoplasm Staging ; Prednisone/administration & dosage ; Prednisone/therapeutic use ; Survival Rate ; Vincristine/administration & dosage ; Vincristine/therapeutic use
SCR Protocol :
ACOPA II protocol
Czasopismo naukowe
Tytuł :
A comparison of doxorubicin and COP for maintenance of remission in cats with lymphoma.
Autorzy :
Moore AS; Department of Small Animal Medicine, Tufts University School of Veterinary Medicine, North Grafton, MA 01536, USA.
Cotter SM
Frimberger AE
Wood CA
Rand WM
L'Heureux DA
Pokaż więcej
Źródło :
Journal of veterinary internal medicine [J Vet Intern Med] 1996 Nov-Dec; Vol. 10 (6), pp. 372-5.
Typ publikacji :
Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Cat Diseases/*drug therapy
Doxorubicin/*therapeutic use
Lymphoma/*veterinary
Animals ; Antineoplastic Agents/standards ; Antineoplastic Combined Chemotherapy Protocols/standards ; Cats ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/standards ; Cyclophosphamide/therapeutic use ; Dose-Response Relationship, Drug ; Doxorubicin/standards ; Female ; Lymphoma/drug therapy ; Male ; Prednisone/administration & dosage ; Prednisone/standards ; Prednisone/therapeutic use ; Remission Induction ; Time Factors ; Vincristine/administration & dosage ; Vincristine/standards ; Vincristine/therapeutic use
SCR Protocol :
COP protocol 2
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies